blue cross blue shield - tennessee policy updates
Track new and updated blue cross blue shield - tennessee policies impacting reimbursement and clinical operations.
| Policy | Payer | Type | Specialty | Change | Effective |
|---|---|---|---|---|---|
| Inclisiran (Leqvio®) | Blue Cross Blue Shield - Tennessee | Clinical | Pharmacy & Specialty Drugs | Modified | Sep 1, 2026 |
| Secukinumab (Cosentyx) — Coverage Criteria | Blue Cross Blue Shield - Tennessee | Clinical | Pharmacy & Specialty Drugs | Modified | Sep 1, 2026 |
| Ryplazim (plasminogen) for plasminogen deficiency type 1 — Coverage Criteria | Blue Cross Blue Shield - Tennessee | Clinical | Hematology/Oncology | Modified | Jul 31, 2026 |
| Zynyz (pembrolizumab?) — indications for select solid tumors | Blue Cross Blue Shield - Tennessee | Clinical | Hematology/Oncology | Modified | Jul 31, 2026 |
| Bortezomib (Velcade®; Bortezomib, Boruzu™) coverage | Blue Cross Blue Shield - Tennessee | Clinical | Hematology/Oncology | Modified | Jul 31, 2026 |
| Selinexor (Sarclisa) — Coverage Criteria for Multiple Myeloma and Related Plasma Cell Disorders | Blue Cross Blue Shield - Tennessee | Clinical | Hematology/Oncology | Modified | Jul 31, 2026 |
| Rivfloza (for primary hyperoxaluria type 1) Coverage Criteria | Blue Cross Blue Shield - Tennessee | Clinical | Nephrology | Modified | Jul 31, 2026 |
| Skysona (gene therapy) for cerebral adrenoleukodystrophy (CALD) | Blue Cross Blue Shield - Tennessee | Clinical | Neurology/Neurosurgery | Modified | Jul 31, 2026 |
| Lamzede (velmanase alfa) for alpha-mannosidosis — Coverage Criteria | Blue Cross Blue Shield - Tennessee | Clinical | — | Modified | Jul 31, 2026 |
| Evinacumab (Evkeeza) for Homozygous Familial Hypercholesterolemia — Coverage Criteria | Blue Cross Blue Shield - Tennessee | Clinical | Cardiology | Modified | Jul 31, 2026 |
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.
OpenPayer by Trek Health — Policy intelligence for billing and revenue cycle teams.
Coverage data is sourced from publicly available payer medical policy documents and updated as payers publish revisions. Read more about where our data comes from. Always consult the primary payer source for clinical decision-making.